By a GenomeWeb staff reporter
By Adam Bonislawski
Proteomics firm Cellzome said this week it has won more than €2.3 million ($3.1 million) in grants funding its participation in three separate research projects.
Plasticell has developed "serum-free protocols that direct the differentiation of Stemnion's stem cells into hard-to-obtain lineages."
Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.
The British stem cell research tools firm plans to use the funds to expand its business development and marketing activities.
The collaboration involves using Sigma-Aldrich's CompoZr zinc finger nuclease technology and Plasticell's CombiCult high-throughput screening system.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.